Related Experiment Video
Updated: Jan 6, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cell death forms in myocardial ischemia-reperfusion injury and their potential clinical applications
Yuantong Xu1, Suying Wu2, Lei Zhang3
1The College of Xinwen, Jinan, Shandong, China.
Abstract:
Timely and effective reperfusion therapy is an effective means of relieving ischemic damage to cardiomyocytes and is also the most commonly used treatment for clinical ischemic heart disease. However, while reperfusion saves the ischemic myocardium, the explosive production of reactive oxygen species (ROS) and calcium overload can cause additional damage to cardiac tissue cells. This review describes the pathophysiological mechanisms of myocardial ischemia-reperfusion injury and the forms of myocardial tissue cell death mediated by the reperfusion process, including ferroptosis, pyroptosis, and necroptosis. We also report the latest research progress in treating myocardial reperfusion injury by targeting ferroptosis, pyroptosis, and necroptosis. The aim is to understand the mechanism of myocardial reperfusion injury better and provide new treatment ideas to reduce myocardial ischemia-reperfusion injury.
Related Concept Videos
Myocarditis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

